pleural disease spontaneous

Upload: desi-ayu-kristiani-pwyllchrestella

Post on 14-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/27/2019 Pleural Disease Spontaneous

    1/14

    BTS guidelines for the management of spontaneouspneumothoraxM Henry, T Arnold, J Harvey, on behalf of the BTS Pleural Disease Group, a subgroupof the BTS Standards of Care Committee. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .

    Thorax2003;58(Suppl II):ii39ii52

    1 INTRODUCTIONPneumothorax is defined as air in the pleural

    spacethat is, between the lung and the chestwall.1 Primary pneumothoraces arise in otherwise

    healthy people without any lung disease. Second-ary pneumothoraces arise in subjects with under-

    lying lung disease. The term pneumothorax was

    first coined by Itard, a student of Laennec, in1803,2 and Laennec himself described the clinical

    picture of pneumothorax in 1819.2 He described

    most pneumothoraces as occurring in patientswith pulmonary tuberculosis, although he recog-

    nised that pneumothoraces also occurred in

    otherwise healthy lungs, a condition he describedas pneumothorax simple. The modern descrip-

    tion of primary spontaneous pneumothoraxoccurring in otherwise healthy people was pro-

    vided by Kjaergard in 1932.3 Primary pneumotho-rax remains a significant global problem, occur-

    ring in healthy subjects with a reported incidence

    of 1828/100 000 per year for men and 1.26/100 000 per year for women.4 5 Secondary pneu-

    mothorax is associated with underlying lung dis-

    ease, whereas primary pneumothorax is not. Bydefinition, there is no apparent precipitating

    event in either. Hospital admission rates for com-

    bined primary and secondary pneumothorax arereported in the UK at between 5.8/100 000 per

    year for women and 16.7/100 000 per year for

    men. Mortality rates in the UK were 0.62/millionper year for women and 1.26/million per year for

    men between 1991 and 1995.6 This guidelinedescribes the management of spontaneous pri-

    mary and secondary pneumothorax. It excludesthe management of trauma. Algorithms for the

    management of spontaneous primary and sec-

    ondary pneumothorax are shown in figs 1 and 2.

    Strong emphasis should be placed on therelationship between the recurrence ofpneumothorax and smoking in an effortto encourage patients to stop smoking.[B]

    Despite the absence of underlying pulmonarydisease in patients with primary pneumothorax,

    subpleural blebsand bullae arelikely to play a rolein the pathogenesis since they are found in up to90% of cases of primary pneumothorax at thora-

    coscopy or thoracotomy and in up to 80% of caseson CT scanning of the thorax. 7 8 The aetiology of

    such bullous changes in otherwise apparently

    healthy lungs is unclear. Undoubtedly, smokingplays a role911; the lifetime risk of developing a

    pneumothorax in healthy smoking men may beas much as 12% compared with 0.1% in non-

    smoking men.11 This trend is also present, though

    to a lesser extent, in women.11 There does notappear to be any relationship between the onset

    of pneumothorax and physical activity.5 Small

    airway obstruction, mediated by an influx ofinflammatory cells, often characterises pneumo-

    thorax and may become manifest in the smaller

    airways of men at an earlier stage. 12 Patients withprimary pneumothoraces tend to be taller than

    control patients.13 14 The gradient in pleural

    pressure increases from the lung base to theapex,1 thus alveoli at the lung apex in tall

    individuals are subject to significantly greaterdistending pressure than those at the base of the

    lung and, theoretically, are more predisposed to

    the development of subpleural blebs.15 Strongemphasis should be placed on the relationship

    between smoking and pneumothorax in an effortto deter those smokers who have developed apneumothorax from smoking. Despite the appar-

    ent relationship between smoking and pneumo-

    thorax, 8086% of young patients continue tosmoke after their first primary pneumothorax.16

    The risk of recurrence of primary pneumothoraxis 54% within the first 4 years, with isolated risk

    factors including smoking, height in male

    patients,14 17 and age over 60 years.17 Risk factors

    for secondary pneumothorax recurrence include

    age, pulmonary fibrosis, and emphysema.17 18

    In an effort to standardise treatment ofprimary and secondary pneumothoraces, theBritish Thoracic Society (BTS) published guide-lines for the treatment of both in 1993.19 Several

    studies suggest that compliance with the 1993guidelines, though improving, remains at only2040% among non-respiratory and A&Estaff.2022 Clinical guidelines have been shown toimprove clinical practice23 24; compliance withguidelines is related to the complexity of practicalprocedures that are described25 and is strength-

    ened by an evidence base.26 Steps in the 1993guidelines which may need clarification include:

    (1) simple aspiration (thoracocentesis) versus

    intercostal tube drainage (tube thoracostomy) asthe first step in the management of primary and

    secondary pneumothoraces, (2) treatment of eld-erly pneumothorax patients or patients with

    underlying lung disease, (3) when to refer

    patients with a difficult pneumothorax to a chestphysician or thoracic surgeon for persistent air

    leak or failure of re-expansion of the lung, and (4)

    treatment of the recurrent pneumothorax. Thisguideline addresses these issues. Its purpose is to

    provide a comprehensive evidence based review

    of the epidemiology, aetiology, and treatment ofpneumothorax to complement the summary

    guidelines for diagnosis and treatment.

    2 CLINICAL EVALUATION AND IMAGING

    Expiratory chest radiographs are not rec-ommended for the routine diagnosis ofpneumothorax. [B]

    See end of article forauthors affiliations. . . . . . . . . . . . . . . . . . . . . . .

    Correspondence to:Dr M Henry, The GeneralInfirmary at Leeds, GreatGeorge Street, LeedsLS1 3EX, UK;[email protected]. . . . . . . . . . . . . . . . . . . . . . .

    ii39

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    2/14

    Figure 1 Recommended algorithm for the treatment of primary pneumothorax.

    P r i m a r y

    p n e u m o t h o r a x

    S t a r t

    B r e a t h l e s s a n d / o r r i m o f a i r > 2 c m

    o n c h e s t r a d i o g r a p h ?

    ( s e c t i o n 4 . 1 )

    A s p i r a t i o n

    C o n s i d e r r e p e a t

    a s p i r a t i o n

    ?S u c c e s s f u l

    ( s e c t i o n 4 . 2 )

    I n t e r c o s t a l d r a i n

    ?S u c c e s s f u l

    ( s e c t i o n 4 . 3 )

    ?S u c c e s s f u l

    ( s e c t i o n 4 . 2 . 1 )

    R e f e r r a l t o c h e s t p h y s i c i a n w i t h i n 4 8 h o u r s

    ?S u c t i o n ( s e c t i o n 4 . 4 . 1 )

    R e f e r r a l t o t h o r a c i c s u r g e o n

    a f t e r 5 d a y s ( s e c t i o n 4 . 5 )

    C o n s i d e r

    d i s c h a r g e

    ( s e c t i o n 4 . 6 )

    R e m o v e 2 4 h o u r s a f t e r

    f u l l r e - e x p a n s i o n / c e s s a t i o n

    o f a i r l e a k w i t h o u t c l a m p i n g

    N O

    Y E S

    Y E S

    Y E S

    Y E S

    N O

    N O

    N O

    ii40 Henry, Arnold, Harvey

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    3/14

    S e c o n d a r y

    p n e u m o t h o r a x

    S t a r t

    B r e a t h l e s s + a g e > 5 0 y e a r s

    + r i m o f a i r > 2 c m

    o n c h e s t r a d i o g r a p h ?

    ( s e c t i o n 4 . 1 )

    I n t e r c o s t a l d r a i n

    R e f e r r a l t o c h e s t

    p h y s i c i a n a f t e r 4 8 h o u r s

    ?S u c t i o n ( s e c t i o n 4 . 4 . 1 )

    ?S u c c e s s f u l

    ( s e c t i o n 4 . 3 )

    ?S u c c e s s f u l

    E a r l y d i s c u s s i o n w i t h

    s u r g e o n a f t e r 3 d a y s

    ( s e c t i o n 4 . 5 )

    C o n s i d e r

    d i s c h a r g e

    ( s e c t i o n 4 . 6 )

    A d m i t t o

    h o s p i t a l f o r

    2 4 h o u r s

    A s p i r a t i o n

    ?S u c c e s s f u l

    ( s e c t i o n 4 . 2 )

    R e m o v e 2 4 h o u r s a f t e r

    f u l l r e - e x p a n s i o n / c e s s a t i o n

    o f a i r l e a k

    Y E S

    Y E S

    N O

    N O

    N O

    N O

    Y E S Y E S

    Figure 2 Recommended algorithm for the treatment of secondary pneumothorax.

    BTS guidelines for the management of spontaneous pneumothorax ii41

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    4/14

    A lateral chest or lateral decubitus radiographshould be performed if the clinical suspicion ofpneumothorax is high, but a PA radiograph isnormal. [B]

    CT scanning is recommended when differentiating apneumothorax from complex bullous lung disease,

    when aberrant tube placement is suspected, andwhen the plain chest radiograph is obscured bysurgical emphysema. [C]

    The clinical history is not a reliable indicator ofpneumothorax size. [C]

    Clinical history and physical examination usually suggest thepresence of a pneumothorax, although clinical manifestations

    are not reliable indicators of size.29 30 In general, the clinicalsymptoms associated with secondary pneumothoraces are

    more severe than those associated with primary pneumotho-

    races, and most patients with a secondary pneumothoraxcomplain of breathlessness which is out of proportion to the

    size of the pneumothorax.31 32 Many patients, particularlythose with primary pneumothoraces, do not seek medical

    advice for several days, 46% waiting more than 2 days with

    symptoms.9 This feature is important because the occurrenceof re-expansion pulmonary oedema (RPO) after re-inflation

    may be related to the length of time the lung has been

    collapsed (see section 4.4.1).33 34

    Arterial blood gas measurements are frequently abnormal

    in patients with pneumothorax with the arterial oxygen ten-sion (PaO2) being less than 10.9 kPa (80 mm Hg) in 75% of

    patients.35 The presence of underlying lung disease along with

    the size of pneumothorax predicts the degree of hypoxaemia.35 Arterial PaO2 was below 7.5 kPa (55 mm Hg)

    and PaCO2 above 6.9 kPa (50 mm Hg) in 16% of cases of

    secondary pneumothorax in the largest reported series.36 Pul-

    monary function tests are weakly sensitive measures of the

    presence or size of pneumothorax and are notrecommended.8

    In both primary and secondary spontaneous pneumothorax

    the diagnosis is normally established by plain chest radio-graphy. In general, expiratory radiographs add little and are

    not indicated as a routine investigation, even in the case of a

    suspected small apical pneumothorax.37 38

    When a pneumo-thorax is suspected but not confirmed by standard postero-

    anterior (PA) chest radiographs, lateral radiographs provideadded information in up to 14% of cases. 39 The lateral decubi-

    tus radiograph is superior to the erect or supine chest

    radiograph and is felt to be as sensitive as CT scanning inpneumothorax detection.40 The upright lateral or lateral decu-

    bitus radiograph is clinically helpful where findings on theupright PA radiograph are unclear. While such small

    pneumothoraces may not have much clinical relevance in

    patients without underlying lung disease, in patients withsuspected secondary pneumothoraces, even small pneumo-

    thoraces may have significant implications and here lateral or

    lateral decubitus radiographs are probably valuable. Inpatients with severe bullous lung disease CT scanning will dif-

    ferentiate emphysematous bullae from pneumothoraces and

    save the patient an unnecessary and potentially dangerousaspiration.41

    3 SIZE OF PNEUMOTHORAX

    The previous classification of the size of a pneumo-thorax tends to underestimate its volume. In thesenew guidelines the size of a pneumothorax is dividedinto small or large depending on the presence ofa visible rim of 2 cm between the lungmargin and the chest wall.

    The plain PA radiograph is a poor method of quantifying the

    size of a pneumothorax as it usually underestimates it. Exact

    methods of estimating size from PA chest radiographs are

    cumbersome and generally used only as a research tool. 42 The

    size of a pneumothorax, in terms of volume, is difficult toassess accurately from a chest radiograph which is a two

    dimensional image. In the 1993 guidelines19 pneumothoraceswere classified into three groups:

    small: defined as a small rim of air around the lung;

    moderate: defined as lung collapsed halfway towardsthe heart border; and

    complete: defined as airless lung, separate from the dia-phragm.

    This attempt to quantify a pneumothorax tends to underesti-

    mate the volume of anything greater than the smallest of

    pneumothoraces.1 Since the volume of a pneumothorax

    approximates to the ratio of the cube of the of the lung diam-

    eter to the hemithorax diameter, a pneumothorax of 1 cm onthePAchest radiograph occupies about 27%of thehemithorax

    volume if the lung is 9 cm in diameter and the hemithorax

    10 cm: (103 93)/103 = 27%. Similarly, a 2 cm radiographicpneumothorax occupies 49% of the hemithorax on the same

    basis (fig 3).In viewof the proximity ofthe lung surface to the chest wall

    in a pneumothorax of

  • 7/27/2019 Pleural Disease Spontaneous

    5/14

    If a patient with a pneumothorax is admittedovernight for observation, high flow (10 l/min) oxy-gen should be administered, with appropriate cau-tion in patients with COPD who may be sensitive tohigher concentrations of oxygen. [B]

    Breathless patients should not be left without inter-vention regardless of the size of the pneumothoraxon a chest radiograph. [C]

    4.1.1 Primary pneumothoraces, minimal symptomsObservation alone is advised for small, closed, mildly sympto-matic spontaneous pneumothoraces.21 30 4648 7080% of pneu-

    mothoraces estimated at smaller than 15% have no persistentair leak and recurrence in those managed with observation

    alone is less than in patients treated with intercostal tube

    drainage.48 Patients with small primary pneumothoraces andminimal symptoms do not require hospital admission, but it

    should be stressed before discharge that they should returndirectly to hospital in the event of developing breathlessness.

    Most patients in this group who fail this treatment and

    require intercostal tube drainage have secondarypneumothoraces.48

    4.1.2 Secondary pneumothoraces, minimal symptomsObservation alone is only recommended in patients with small

    secondary pneumothoraces of less than 1 cm depth or isolatedapical pneumothoraces in asymptomatic patients. Hospitalisa-

    tion is recommended in these cases. All other cases will

    require active intervention (aspiration or chest drain inser-tion, see later sections).

    4.1.3 Symptomatic pneumothoraces, primary orsecondaryObservation alone is inappropriate and active intervention is

    required. Marked breathlessness in a patient with a small

    (

  • 7/27/2019 Pleural Disease Spontaneous

    6/14

    4.2.1 Repeat aspiration and catheter aspiration of simplepneumothorax

    Repeated aspiration is reasonable for primary pneu-mothorax when the first aspiration has been unsuc-cessful (i.e. patient still symptomatic) and a volumeof 2.5 l was

    aspirated during the unsuccessful first attempt.56 Catheter

    aspiration of simple pneumothorax (CASP) involves a small(8 F) catheter being passed over a guidewire into the pleural

    space. A three way stopcock is attached and air may be

    aspirated via a 50 ml syringe. This controls up to 59% of all

    pneumothoraces. Addition of a Heimlich valve and suctionmay improve success rates further.5759

    4.3 Intercostal tube drainage

    If simple aspiration or catheter aspiration drainageof any pneumothorax is unsuccessful in controllingsymptoms, then an intercostal tube should beinserted. [B]

    Intercostal tube drainage is recommended in second-ary pneumothorax except in patients who are notbreathless and have a very small (50%, primary failure rates for aspiration are

    estimated at >50%.

    51 52 66

    Age alone is a strong predictor offailure of simple aspiration (>50 years, success 2767%), 51 52

    although in those over the age of 50 years with no evidence of

    pre-existing lung disease there is no evidence that tube drain-age should be recommended before simple aspiration as

    primary treatment.

    Analgesic use during the insertion of intercostal tubesremains poorly studied. The injection of intrapleural local

    anaesthetic (2025 ml = 200250 mg, 1% lignocaine) given as

    a bolus and at eight hourly intervals as necessary after theinsertion of the drain significantly and safely reduced pain

    scores without affecting blood gas measurements, either with

    or without chemical pleurodesis. There are no data detailingthe incidence of pleural infection with this technique.67 68

    Chest tubes frequently (59%) end up in fissures,69 but thesetubes seem to retain their effectiveness. Step by step

    guidelines to chest drain insertion are described elsewhere inthese guidelines (page ii53).

    4.3.1 Complications of intercostal tube drainageThe complications of intercostal tube drainage includepenetration of the major organs such as lung, stomach, spleen,

    liver, heart and great vessels, and are potentially fatal.63 7073

    These complications occur more commonly when a sharpmetal trocar is inappropriately applied during the

    procedure.63 72 73

    In the largest series reviewing complications of tube drain-

    age in recent times, Chan and colleagues74 identified

    complications in 18% of chest drain insertions for allindications; 64% of these chest tubes (n=373) were inserted

    for treatment of pneumothorax. However, 15% of the compli-

    cations identified involved failure of resolution of thepneumothorax and only 4% involved aberrant tube place-

    ment. Notably, complications related to tube placement

    occurred most commonly on medical wards. CT assessmentsuggests a higher rate of incorrect tube placement. Baldt and

    colleagues75 identified 3% of tubes placed extrathoracicallyand 6% placed within the lung during the treatment of pneu-

    mothoraces. This highlights the need for correct training in

    chest tube placement. In some circumstances, thoracic CTscanning is valuable for assessing chest tube positionfor

    example, when misplacement is suspected but not confirmed

    on a plain radiograph.75

    Pleural infection is another complication of intercostal tube

    drainage. The rate of empyema after chest tube insertion has

    ii44 Henry, Arnold, Harvey

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    7/14

    been estimated as 1%.74 Other series have reported anincidence of up to 6% of chest tube related empyema intrauma cases and suggested that the administration ofprophylactic antibiotics should be considered, particularly

    where a prolonged period of chest tube drainage might beanticipated.76 77 This highlights the need for full aseptictechnique in the insertion or manipulation of any chest drain-age system.

    Finally, surgical emphysema is a well recognised complica-tion of intercostal tube drainage.78 This is generally of cosmetic

    importance only, subsiding after a few days. The developmentof surgical emphysema associated with pneumothorax in-

    volves an air filled space, not formerly in communication withthe subcutaneous tissue, being brought into communication

    with the subcutaneous tissues. This may occur in the presenceof a malpositioned, kinked, blocked, or clamped tube.Likewise, a small tube in the presence of a very large leak maypotentially cause surgical emphysema. Occasionally, theresulting acute airway obstruction or thoracic compressionmay lead to respiratory compromise.78 79 The treatment isusually conservative but, in life threatening situations,tracheostomy, skin incision decompression, and insertion oflarge bore modified subcutaneous chest drains have all beenused.78

    4.3.2 Size of tube

    There is no evidence that large tubes (2024 F) areany better than small tubes (1014 F) in the manage-ment of pneumothoraces. The initial use of large(2024 F) intercostal tubes is not recommended,although it may become necessary to replace a smallchest tube with a larger one if there is a persistent airleak. [B]

    Although one study suggested that success rates for the treat-ment of pneumothoraces with small chest tubes (13 F) were

    poor and that larger sized catheters should be used,80

    subsequent studies have not confirmed this and suggest thatsmaller calibre chest tubes are just as effective.8184 Primary

    success rates of 8497% were recorded in these studies usingdrains of 79 F gauge. Recent technical developments have

    allowed the addition of a Heimlich flutter valve to small tubes

    as well as to larger bore tubes.Factors which might predispose to small tube failure, thus

    favouring the choice of a larger tube, would be the presence ofpleural fluid and the presence of a large air leak which exceedsthe capacity of the smaller tubes.82 The use of an indwellingsmall lumen Teflon catheter (2 mm) inserted over needle andguidewire attached to a flutter valve after partial aspiration

    with a 60 ml syringe proved successful in 27 of 28 patientswith a mean drainage time of 48 hours.59 Using a small calibrechest drain system, the median duration of drainage rangedfrom 2 to 4 days, which compares very favourably with largerintercostal tube drainage systems.59 82 83 Difficulties with tubeblockage were not encountered in any of these studies.Chemical pleurodesis is still possible through smaller tubesincluding indwelling catheter systems.

    If the decision is made to insert a chest drain, small(1014 F) systems should be used initially. The use of catheterover guidewire systems (Seldinger technique) may prove to beas safe and effective as small calibre tubes, although they aremore expensive. They are being used with increasingfrequency, but further evidence is required before they can berecommended for initial use.

    4.4 Referral to respiratory specialists

    Pneumothoraces which fail to respond within 48hours to treatment should be referred to a respira-tory physician. [C]

    Failure of a pneumothoraxto re-expand or a persistent airleakexceeding 48 hours duration should prompt referral to a res-

    piratory physician. Such patients may require sustained chestdrainage with complex drain management (suction, chest

    drain repositioning) and thoracic surgery decisions. These

    issues will be better managed by physicians with specifictraining and experience in these problems and established

    relationships with a thoracic surgeon. Drain management isalso best delivered by nurses with substantial experience in

    this area.

    4.4.1 Chest drain suction

    Suction to an intercostal tube should not be applieddirectly after tube insertion, but can be added after48 hours for persistent air leak or failure of apneumothorax to re-expand. [B]

    High volume, low pressure (10 to 20 cm H2O)suction systems are recommended. [C]

    Patients requiring suction should only be managedon lung units where there is specialist medical andnursing experience. [C]

    There is no evidence to support the routine initial use of suc-

    tion applied to chest drain systems in the treatment of spon-

    taneous pneumothorax.80 85A persistent air leak, with or with-

    out incomplete re-expansion of the pneumothorax on a chest

    radiograph, is the usual reason for applying suction to an

    intercostal tube system. A persistent air leak is usuallyarbitrarily defined as a continued air bubbling through an

    intercostal tube 48 hours after insertion. Mathur andcolleagues86 retrospectively reviewed 142 cases of spontaneous

    pneumothorax requiring chest drain insertion. The median

    time to resolution was 8 days (19 days in those withunderlying lung disease), which was not related to the initial

    size of the pneumothorax. Most of the patients (30/43) with apersistent air leak had suction applied, but without standardi-

    sation of the degree of suction or of the point of initiation (the

    first 4 days in the majority). Normal intrapleural pressures are8 cm H2O during inspiration and 3.4 cm H2O during expira-

    tion. During intercostal tube drainage various factors influ-ence the amount of suction applied to the pleural space. 63 87 It

    has been suggested that, because the magnitude of these

    physiological factors varies, it is desirable to apply 10 to

    20 cm H2O suction to all pneumothoraces which are slow tore-expand, and the system used should have the capacity to

    increase the suction with an air flow volume of 1520 l/min. 88

    Over 40 years ago Roe89 stressed the importance of high

    volume vacuums to drain the pleural space during pneumot-horaces. The use of high pressure, high volume suction is not,

    however, recommended because of the ease with which it can

    generate high air flow suction which may lead to air stealing,hypoxaemia, or the perpetuation of persistent air leaks.90 Like-

    wise, high pressure, low volume systems should be avoided.64

    High volume, low pressure systems such as a Vernon-Thompson pump or wall suction with an adaptor to reduce

    pressure are recommended. Unfortunately, due to the lack ofmore recent randomised controlled trials examining the role

    of suction with intercostal tube systems, evidence based

    recommendations cannot be applied. The best practice fromprevious studies to date, as above, suggests that suction should

    be applied after 48 hours, but that surgical referral for a

    persistent air leak in those without pre-existing lung diseaseshould be made at 57 days. Significantly, earlier referral (24

    days) should be considered in those with underlying disease,

    a large persistent air leak, or failure of the lung tore-expand.9193 If suction is to be applied to a chest drain, it is

    recommended that the patient should be situated in an areawhere specialist nursing experience is available.

    The addition of suction too early after the insertion of a

    chest tube, particularly in the case of a primary pneumo-thorax which may have been present for a few days, may

    precipitate re-expansion pulmonary oedema (RPO) and is

    BTS guidelines for the management of spontaneous pneumothorax ii45

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    8/14

    contraindicated. RPO is probably caused by the increased per-

    meability of capillaries damaged during a pneumothorax. This

    becomes manifest as oedema during re-expansion due to fur-ther mechanical stresses applied to the already leaky

    capillaries.94 Clinically, these patients manifest symptoms ofcoughing and breathlessness or chest tightness after insertion

    of the chest tube. In those whose symptoms persist, a repeat

    chest radiograph after 24 hours will often show pulmonaryoedema in the treated lung, although pulmonary oedema may

    also develop in the contralateral lung.95 The incidence of RPO

    may be up to 14% and is higher in those with larger primarypneumothoraces and in younger patients (

  • 7/27/2019 Pleural Disease Spontaneous

    9/14

    persistent air leaks had resolved their air leaks by 14 days with

    no mortality. However, considering the efficacy and relatively

    lowlevels of morbidityand recurrence associated with surgeryfor pneumothorax,109112 earlier surgical intervention has been

    advocated for persistent air leak or failure of re-expansion,particularly in cases of secondary pneumothorax.92 113 Several

    authors have recommended operative referral/intervention as

    early as 3 days for a persistent air leak. However, these studieswere not controlled.91 93 Despite the reduction in the incidence

    of late recurrence of pneumothorax in many of these studies,

    surgical referral for a persistent air leak in a first primarypneumothorax within the first 45 days is not supported by

    the literature. However, best practice suggests that protracted

    chest tube drainage is not in the patients interest. It is there-fore recommended that patients with difficult pneumothora-

    ces should receive care from a respiratory physician and that athoracic surgical opinion will be an early part of management.

    According to the statistical and perceived risk of recurrence,accepted indications for operative intervention are as follows:

    Second ipsilateral pneumothorax

    First contralateral pneumothorax

    Bilateral spontaneous pneumothorax

    Persistent air leak (>57 days of tube drainage; air leak orfailure to completely re-expand)

    Spontaneous haemothorax Professions at risk (e.g. pilots, divers)108 110 114116

    4.5.1 Surgical strategiesThere are two objectives in the surgical management of a

    pneumothorax. The first widely accepted objective is resection

    of blebs or the suture of apical perforations to treat the under-lying defect. The second objective is to create a pleural

    symphysis to prevent recurrences. There is debate between

    those who favour surgical pleurodesis or pleural abrasion ver-sus those who favour partial or total pleurectomy as a defini-

    tive treatment to prevent recurrence of pneumothorax, 109 117 118

    although a relatively recent comprehensive review of this area

    suggests a slight advantage of pleurectomy over pleural abra-

    sion with a recurrence rate of 0.4% after pleurectomy (n=752)and 2.3% after pleural abrasion (n=301).109 Operative tech-

    niques have tended towards minimally invasive procedures

    over the last few years. In order to be considered effective,these techniques should yield results comparable to the gold

    standard open thoracotomy procedurethat is, the operative

    morbidity should be less than 15% and the pneumothoraxrecurrence rate should be less than 1%.37 99 112

    Open thoracotomyIn 1941 Tyson and Crandall119 described pleural abrasion as a

    treatment for pneumothorax and in 1956 Gaensler 117 intro-

    duced parietal pleurectomy for recurrent pneumothorax. Thisprocedure produces uniform adhesions between the pleura

    and the chest wall. Both of these techniques are designed to

    obliterate the pleural space by creating symphysis between thetwo pleural layers or between the visceral pleura and subpleu-

    ral plane, in the case of parietal pleurectomy. In order to pre-vent recurrence, however, an appropriate closure at the site ofthe pleural airleak is essentialeither by cauterisation, ligation,

    or suture of accompanying blebs.116 Open thoracotomy yieldsthe lowest postoperative recurrence results. Bulla ligation/

    excision, thoracotomy with pleural abrasion, and either apical

    or total parietal pleurectomy all have failure rates under0.5%.48 110 Morbidity from thoracotomy for pneumothorax has

    an overall incidence of 3.7%, mostly in the form of sputumretention and postoperative infection.110 Open thoracotomy is

    generally performed using single lung ventilation, a limited

    posterolateral thoracotomy allowing parietal pleurectomy,excision, or stapling of bullae or pleural abrasion.120 Isolated

    lung ventilation during open thoracotomy facilitates full visu-

    alisation of the visceral pleura. This may not be possible dur-

    ing a VATS procedure, increasing the risk of missing a leaking

    bulla.121123 Open thoracotomy may be associated with in-creased postoperative respiratory dysfunction and hospital

    stay compared with VATS procedures.120 It is suggestedthat thesuccess rates with the open procedure are higher.124 Thus, sur-

    gical authorities suggest open thoracotomy in patients with

    secondary pneumothoraces who may have extensive pleuraldisease requiring more extensive pleurectomy, subpleural

    bullectomy, or pleural abrasion.110 114 125

    Surgical chemical pleurodesis

    Surgical chemical pleurodesis is best achieved with5 g sterile talc. Side effects such as ARDS andempyema are reported but rare. [A]

    The use of talc pleurodesis is now a subject of renewed inter-

    est because of the potential unavailability of tetracycline, its

    low cost, and a record of successful pleurodesis (8592%) thatis similar to alternative thoracoscopic techniques for compli-

    cated pneumothorax.99 114 126 127While talc slurry inserted undermedical supervision via intercostal tube drainage tends to be

    less favoured than thoracoscopic talc poudrage, both methods

    have been shown to be effective. The overall success rate fortalc pleurodesis reviewed by meta-analysis is 91%.126 Surgical

    pleurodesis with tetracycline is not generally felt to be a satis-

    factory alternative, with recurrence rates of 16% in a series of390 patients who underwent surgical pleurodesis using

    tetracycline.98 There are no controlled trials comparing painduring talc pleurodesis with that using other agents, although

    it is suggested that talc pleurodesis is no more difficult or

    painful a procedure than tetracycline pleurodesis.128132 Dos-ages of talc ranging from 2 g to 10 g have been used, but the

    suggestion that higherdosages aremore effective has not been

    established by controlled trials. On the basis of a meta-analysis of uncontrolled data, 5 g talc by VATS is recom-

    mended with a success rate of 87%, which is very close to thesuccess rates using more extensive operative approaches.126

    Side effects reported with talc pleurodesis include five cases of

    adult respiratory distress syndrome (ARDS), although the riskof ARDS may be related to the size of talc particles used 133;

    empyema, although this is rare when properly sterilised talc isused126 134 135; pneumonia; and respiratory failure.134 In view of

    these potential side effects, standard first line usage of talc

    poudrage or talc slurry pleurodesis should be approached withcaution since surgery not dependent on introducing a foreign

    agent is usually an option. Lower dosages of 25 g should be

    used until dosage schedules and effectiveness have been clari-fied. Long term safety does not appear to be an issue if

    asbestos-free talc is used. The success rates with talc poudrage

    and talc slurry pleurodesis are similar, so either approach canbe recommended. Because of the relatively high failure rates

    of over 9% with talc pleurodesis compared with surgical pleu-

    ral stripping procedures, talc pleurodesis should not beconsidered as initial treatment for primary spontaneous

    pneumothorax requiring surgical intervention. In thosepatients who are either unwilling or too unwell to undergo

    general anaesthesia, medical pleurodesis with either tetra-

    cycline or talc (via an intercostal tube) is recommended.

    Transaxillary minithoracotomyBecker and Munro136 pioneered this technique in the 1970s.

    The procedure is considered a minimally invasive procedure.

    The incision in the axillary margin measures 56 cm. Apicalpleurectomy or abrasion may be performed and the apex care-

    fully inspected for pleural blebs or bullae which may be

    stapled. The largest series examining this technique reporteda mean hospital stay of 6 days, a recurrence rate of 0.4%, and

    a complication rate of 10%, most of which were minor.125 Theseresults make this procedure a realistic alternative to open

    BTS guidelines for the management of spontaneous pneumothorax ii47

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    10/14

    thoracotomy for the treatment of complicated spontaneous

    pneumothorax.

    Video assisted thoracoscopic surgery (VATS)The evaluation of VATS for spontaneous pneumothorax is lim-

    ited by the small number of randomised trials comparing it

    with alternative surgical approaches. To date, there have onlybeen two randomised studies which have attempted to define

    the role of VATS in the treatment of spontaneouspneumothorax.120 137 In a comprehensive review, Massard and

    colleagues99

    have suggested that the impression that VATS issuperior to open procedures in terms of morbidity, time inhospital, and cost may not be wholly correct. Minimally

    invasive surgery may have a complication rate similar to open

    procedures at about 810%.120 122 138 Recurrence rates of

    pneumothorax after VATS are 510%,114 127 which are higher

    than the 1% rates reported after open procedures.110 Whilebullectomy, pleurectomy, pleural abrasion, and surgical pleu-

    rodesis have all been shown to have reasonable success rates

    when carr ied out thoracoscopically,120 122 128 139141 there are con-cerns associated with VATS performed under local anaesthetic

    supplemented by nitrous oxide inhalation. These arise from

    the inability to obtain isolated single lung ventilation andinclude difficulties in inspecting the entire visceral pleural

    surface, increasing the risk of missing a leaking bleb orbulla.123 142 It is also suggested that a less intense pleural

    inflammatory reaction is induced by VATS procedures leading

    to a less effective pleurodesis.143 Several authors suggest thatVATS offers significant advantages over open thoracotomy

    including a shorter postoperative hospital stay,114 120 127 138 142

    significantly less postoperative pain,120 125 143 144 and better

    pulmonary gas exchange in the postoperative period. 145 How-

    ever, Kim and colleagues in their randomised controlled trialdid not confirm a shorter postoperative stay in the VATS

    groups.137

    Further randomised trials comparing VATS with transaxil-lary and open thoracotomies are required and, until these data

    are available, VATS cannot be considered to be established asbeing superior to thoracotomy.144 Waller and colleagues146 sug-

    gested that, while VATS may be the preferred surgical

    procedure for young fit people with complicated or recurrent

    primary pneumothoraces, it is less reliable in cases of second-ary pneumothorax.In cases of secondary pneumothorax, open

    thoracotomy and repair is still the recommended approachand VATS procedures should be reserved for those who might

    not tolerate an open procedure because of poor lung function.

    4.6 Discharge and follow up

    Patients discharged without intervention shouldavoid air travel until a chest radiograph has con-firmed resolution of the pneumothorax. [C]

    Diving should be permanently avoided after a pneu-mothorax, unless the patient has had bilateral surgi-cal pleurectomy. [C]

    Primary pneumothorax patients treated successfullyby simple aspiration should be observed to ensure

    clinical stability before discharge. Secondary pneu-mothorax patients who are successfully treated withsimple aspiration should be admitted for 24 hoursbefore discharge to ensure no recurrence. [C]

    Patients with spontaneous pneumothoraces who are dis-

    charged without active intervention should be advised toreturn for a follow up chest radiograph after 2 weeks. These

    patients should be cautioned against flying until a follow up

    chest radiograph confirms full resolution of the pneumotho-rax. Commercial airlines currently arbitrarily advise that there

    should be a 6 week interval between having a pneumothoraxand travelling by air. A recent chest radiograph should confirm

    resolution of the pneumothorax. A patient with a current

    closed pneumothorax should not travel on a commercialflight. There is no evidence that air travel precipitates

    recurrence of a pneumothorax, but recurrence during a flight

    may have serious repercussions. The BTS Air Travel WorkingParty stress that patients may travel safely 6 weeks after a

    definitive surgical procedure or resolution of the pneumotho-

    rax on the chest radiograph. Otherwise, there is still a signifi-cant risk of recurrence for up to 1 year, depending on whether

    the patient has underlying lung disease or not. Patients,

    particularly those who have suffered a secondary spontaneous

    pneumothorax, may decide to avoid the risk by avoiding flyingfor a year in the absence of a definitive surgical procedure.147

    After a pneumothorax, diving should be discouraged per ma-nently unless a very secure definitive prevention strategy such

    as surgical pleurectomy has been performed.148 The BTS

    guidelines on respiratory aspects of fitness for diving149 dealwith this in greater detail.

    Patients with primary pneumothorax treated successfully

    by simple aspiration should be observed to ensure clinical sta-bility before discharge. The few patients with secondary

    pneumothorax who are successfully treated with simple aspi-

    ration should be admitted at least overnight and preferably for24 hours before discharge to ensure no recurrence. The

    mortality rate associated with secondary pneumothorax is10%, and many of these patients die after the pneumothorax

    has resolved.

    18 32

    Most patients with secondary pneumothoraxwill require a more protracted admission, including treatmentof their underlying lung disorder.32 All patients discharged

    after active treatment or otherwise should be given verbal andwritten advice to return to the Accident and Emergency

    department immediately should they develop further breath-

    lessness.

    5 PNEUMOTHORAX AND AIDS

    Early and aggressive treatment of pneumothoracesin HIV patients, incorporating intercostal tubedrainage and early surgical referral, is recommended.[B]

    There is evidence that the clinical spectrum of spontaneous

    pneumothorax is shifting away from the predominant

    subpleural bleb disease as emphasised by most reports sinceKjaergard.3 There are several reports that up to 25% of sponta-neous pneumothoraces in large urban settings with a high

    prevalence of HIV infection are AIDS related31 32 150; 25% of

    AIDS patients will develop a pneumothorax.151153 Pneumocystis

    carinii infection should be considered as the most likely

    aetiology in any HIV positive patient who develops a

    pneumothorax, although the administration of aerosolisedpentamidine has also been suggested as an independent risk

    factor.151 Pneumocystis carinii pneumonia (PCP) is associatedwith a severe form of necrotising alveolitis in which the sub-

    pleural pulmonary parenchyma is replaced by necrotic thin

    walled cysts and pneumatoceles.154 155 AIDS related spontane-ous pneumothorax is complicated by the refractory nature of

    air leaks which tend to occur with the necrotising subpleural

    pneumonitis of PCP infection.

    156

    Such is the relationshipbetween AIDS related pneumothorax and the presence of P

    carinii that the occurrence of pneumothorax in AIDS patientsis considered an indicator of treatment for active P carinii

    infection.151 AIDS related spontaneous pneumothorax carr ies

    a higher hospital mortality, a higher incidence of bilateral(40%) and recurrent pneumothoraces, and more prolonged air

    leaks.157 Treatment failures may also reflect the degree ofimmunocompromise of the impaired host as reflected by the

    CD4 counts.157 It has also been suggested that systemic

    corticosteroids used to treat PCP may increase the risk of mor-bidity from AIDS related pneumothorax.158 Because of the

    high rate of primary treatment failures and associated short

    survival times reported for such patients,159 160 early and

    ii48 Henry, Arnold, Harvey

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    11/14

    aggressive treatment of AIDS related spontaneous

    pneumothoraxincorporating early tube drainage and talc

    pleurodesis, early VATS assisted talc poudrage, unilateral orbilateral pleurectomyis recommended.150 152 157 158 161 162

    6 PNEUMOTHORAX AND CYSTIC FIBROSIS

    Early and aggressive treatment of pneumothoracesin cystic fibrosis is recommended. [C]

    Surgical intervention should be considered after the

    first episode, provided the patient is fit for the proce-dure. [C]

    The treatment of pneumothorax for patients with cystic fibro-sis (CF) is similar to that for non-CF patients. A pneumotho-

    rax is associated with more severe disease and can be lifethreatening. Median survival after pneumothorax in patients

    with CF is 30 months and the occurrence reflects the severity

    of the underlying disease rather than being an independentrisk factor.163 Contralateral pneumothoraces occur in up to 40%

    of patients.163 164 A small pneumothorax without symptomscan be observed or aspirated. Larger pneumothoraces require

    treatment with intercostal tube drainage. The leak is usually

    from the upper lobes and it is important to site the tube in thecorrect place. The collapsed lung can be stiff and take a long

    time to re-expand. It is important to commence intravenous

    antibiotics at the same time to prevent sputum retention,which can delay re-expansion of the collapsed lung. Pleurec-

    tomy, pleural abrasion, and talc pleurodesis all have markedly

    lower reported recurrence rates than observation or tube tho-racostomy alone, which has an unacceptably high recurrence

    rate of 50%.165167 Partial pleurectomy has a success rate of 95%with little reduction in pulmonary function associated with

    surgery, and it is generally felt to be the treatment of choice in

    CF patients with recurrent pneumothoraces who are fit toundergo surgery.163 In those patients who are too ill to undergo

    surgery, it can take 23 weeks for the lung to re-expand withintubation and suction. In this group, talc instillation or

    repeated instillation of the patients own blood are effective

    alternatives.163 Although not an absolute contraindication totransplantation, sclerosants can make transplantation more

    difficult. It takes longer to remove the lungs, prolonging the

    ischaemic time for the donor lungs, and is associated withexcessive bleeding.168

    7 TENSION PNEUMOTHORAX

    If tension pneumothorax is present, a cannula ofadequate length should be promptly inserted intothe second intercostal space in the mid clavicular lineand left in place until a functioning intercostal tubecan be positioned. [B]

    Tension pneumothorax occurs when the intrapleural pressure

    exceeds the atmospheric pressure throughout inspiration as

    well as expiration. It is thought to result from the operation ofa one way valve system, drawing air into the pleural space

    during inspiration and not allowing it out during expiration.

    The development of tension pneumothorax is often, but notalways, heralded by a sudden deterioration in the cardiopul-

    monary status of the patient related to impaired venous

    return, reduced cardiac output, and hypoxaemia.169 170 The

    development of tension in a pneumothorax is not dependent

    on the size of the pneumothorax and the clinical scenario oftension pneumothorax may correlate poorly with chest radio-

    graphic findings. The clinical status is striking. The patient

    rapidly becomes distressed with rapid laboured respiration,cyanosis, sweating, and tachycardia. It should be particularly

    suspected in those on mechanical ventilators or nasalnon-invasive ventilation who suddenly deteriorate or develop

    EMD arrest, and is frequently missed in the ICU setting.171 If a

    tension pneumothorax occurs, the patient should be given

    high concentration oxygen and a cannula should be intro-

    duced into the pleural space, usually in the second anterior

    intercostal space mid clavicular line. Air should be removeduntil the patient is no longer compromised and then an inter-

    costal tube should be inserted into the pleural space as previ-

    ously described. Advanced Trauma Life Support guidelinesrecommend the use of a cannula 36 cm long to perform

    needle thoracocentesis for life threatening tensionpneumothorax.172 However, in 57% of patients with tension

    pneumothorax the thickness of the chest wall has been found

    to be greater than 3 cm. It is therefore recommended that acannula length of at least 4.5 cm should be used in needle

    thoracocentesis of tension pneumothoraces.173 174 The cannulashould be left in place until bubbling is confirmed in the

    underwater seal system to confirm proper function of the

    intercostal tube.169

    8 IATROGENIC PNEUMOTHORAXThe incidence of iatrogenic pneumothorax is high, outnum-bering spontaneous pneumothoraces in several large review

    series.175 176 Transthoracic needle aspiration (24%), subclavian

    vessel puncture (22%), thoracocentesis (22%), pleural biopsy(8%), and mechanical ventilation (7%) are the five leading

    causes.173 The two primary risk factors related to the develop-ment of pneumothorax with transthoracic needle aspiration

    are the depth of the lesion and the presence of COPD.

    177

    Todate, no method has been found to prevent pneumothoraxfollowing needle aspiration/thoracocentesis. While it was

    hoped that positioning the patient so that the area to be biop-

    sied was dependent might reduce the incidence of suchevents, this has not been shown to be the case.178 The

    treatment of iatrogenic pneumothorax tends to be simple asthere is less likelihood of recurrence. The majority will resolve

    with observation alone. If required, treatment should be by

    simple aspiration. Delius and coworkers58 aspirated up to 89%without resorting to tube drainage using a small 8 F teflon

    catheter. Patients with COPD who develop an iatrogenic

    pneumothorax are more likely to require tube drainage,179 and

    patients who develop a pneumothorax while on positive pres-

    sure ventilation should be treated with a chest drain unlessimmediate weaning from positive pressure ventilation is pos-

    sible, as positive pressure ventilation maintains the air leak. 180

    9 CONCLUDING REMARKSThe 1993 BTS pneumothorax guidelines emphasised the place

    of simple observation and aspiration, reminded junior doctorsof the potential hazards of chest drain insertion, and encour-

    aged shorter, safer and less painful treatment paths for many

    patients. Despite their usefulness, recent evidence suggeststhat adherence to these guidelines may be suboptimal. This

    revision endorses the main thrust of these guidelines, with

    observation for the least severe cases, simple aspiration as theinitial treatment choice, and chest drain insertion as a last

    resort. Recently, the American College of Chest Physicians

    (ACCP) has published its own guidelines which were arrivedat by the Delphi consensus method.65 These guidelines are

    similar to our proposed guidelines in many respects, althoughthere are differences such as the emphasis placed on the value

    of simple aspiration in the treatment of primary pneumotho-

    rax.Both sets of guidelines will undoubtedly stimulate debate.The evidence for the current BTS recommendations is

    incorporated and its weaknesses described. This revision alters

    the threshold for aspiration in primary pneumothorax andsuggests a place for re-aspiration. The limitations of aspiration

    in secondary pneumothorax are acknowledged, and initialchest drain insertion is recommended for categories of

    patients where aspiration is unlikely to succeed. These issues

    are already being revisited as the new pneumothorax kitsinserted with a Seldinger technique and containing integral

    Heimlich type flutter valves gain popularity. It is likely that

    BTS guidelines for the management of spontaneous pneumothorax ii49

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    12/14

    they will prove to be as successful and possibly replace simpleaspiration followed by immediate removal of the catheter as

    recommended in these guidelines.

    Several aspects of management that were not previouslycovered are now included. These include the place of CT scan-

    ning in diagnosis, which patients to refer for surgery, a discus-

    sion of surgical techniques, and issues such as intercostal tubesize and the place of suction and pleurodesis. Complex

    scenarios including tension pneumothorax, subcutaneous

    emphysema, pneumothorax in HIV disease and adult CF arealso discussed. It is hoped that these changes build on the

    clinical benefits produced by the first set of guidelineswhichif adhered toshould, we calculate, prevent approxi-

    mately 7000 unnecessary chest drain insertions every year in

    the UK.

    . . . . . . . . . . . . . . . . . . . . .

    Authors affiliationsM Henry, Department of Respiratory Medicine, The General Infirmary atLeeds, Great George Street, Leeds LS1 3EX, UKT Arnold, Medical Chest Unit, Castle Hill Hospital, Cottingham, NorthHumberside HU16 5JQ, UKJ Harvey, Department of Respiratory Medicine, Southmead Hospital,Bristol BS10 5NB, UK

    REFERENCES1 Light RW. Pneumothorax. In: Pleural diseases. 3rd ed. Baltimore:

    Williams and Wilkins, 1995: 24277.2 Laennec RTH. Trait de lauscultation mediate et des maladies des

    poumons et du coeur. Tome Second. Paris, 1819.3 Kjaergard H. Spontaneous pneumothorax in the apparently healthy.

    Acta Med Scand (Suppl) 1932;43:1159.4 Melton LJ, Hepper NCG, Offord KP. Incidence of spontaneous

    pneumothorax in Olmsted County, Minnesota: 19501974. Am RevRespir Dis 1979;29:137982. [III]

    5 Bense L, Wiman LG, Hedenstierna G. Onset of symptoms inspontaneous pneumothorax: correlations to physical activity. Eur J RespirDis 1987;71:1816. [III]

    6 Gupta D, Hansell A, Nichols T, et al. Epidemiology of pneumothorax inEngland. Thorax2000;55:66671. [III]

    7 Donahue DM, Wright CD, Viale G, et al. Resection of pulmonary blebsand pleurodesis for spontaneous pneumothorax. Chest1993;104:17679. [IIb]

    8 Lesur O, Delorme N, Frogamet JM, et al. Computed tomography in theaetiological assessment of idiopathic spontaneous pneumothorax. Chest1990;98:3417. [IIa]

    9 OHara VS. Spontaneous pneumothorax. Milit Med1978;143:325.[III]

    10 Jansveld CA, Dijkman JH. Primary spontaneous pneumothorax andsmoking. BMJ1975;4:55960. [IIa]

    11 Bense L, Eklund G, Odont D, et al. Smoking and the increased risk ofcontracting pneumothorax. Chest1987;92:100912. [IIa]

    12 Schramel FM, Meyer CJ, Postmus PE. Inflammation as a cause ofspontaneous pneumothorax and emphysematous-like changes: results ofbronchoalveolar lavage. Eur Respir J1995;8:397s. [IIb]

    13 Withers JN, Fishback M.E, Kiehl PV, et al. Spontaneous pneumothorax.

    Am J Surg 1964;108:7726. [IV]14 Sadikot RT, Greene T, Meadows K, et al. Recurrence of primarypneumothorax. Thorax1997;52:8059. [III]

    15 West JB. Distribution of mechanical stress in the lung, a possible factor inlocalisation of pulmonary disease. Lancet1971;i:83941. [IIb]

    16 Smit HJM, Chatrou M, Postmus PE. The impact of spontaneouspneumothorax and its treatment on the smoking behaviour of young adultsmokers. Respir Med1998;92:11326. [III]

    17 Lippert HL, Lund O, Blegrad S, et al. Independent risk factors forcumulative recurrence rate after first spontaneous pneumothorax. EurRespir J1991;4:32431. [III]

    18 Videm V, Pillgram-Larsen J, Ellingsen , et al. Spontaneouspneumothorax in chronic obstructive pulmonary disease: complications,treatment and recurrences. Eur J Respir Dis 1987;71:36571. [III]

    19 Miller AC, Harvey JE. Guidelines for the management of spontaneouspneumothorax. BMJ. 1993;307:1146. [IV]

    20 Soulsby T. British Thoracic Society guidelines for the management ofspontaneous pneumothorax: do we comply with them and do they work?

    J Accid Emerg Med 1998;15:31721. [III]21 Selby CD, Sudlow MF. Deficiencies in the management of spontaneous

    pneumothoraces. Scot Med J1994;39:756. [III]

    22 Yeoh JH, Ansari S, Campbell IA. Management of spontaneouspneumothorax : a Welsh survey. Postgrad Med J2000;76:4969. [III]

    23 Grimshaw JM, Russell IT. Effect of clinical guidelines on medicalpractice: a systematic review of rigorous evaluation. Lancet1993;342:131721. [IIb]

    24 Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between researchand practice: an overview of systematic reviews of interventions topromote the implementation of research findings. BMJ1998;317:4658.[Review]

    25 Grilli R, Lomas J. Evaluating the message: the relationship betweencompliance rate and the subject of a practice guideline. Med Care1994;32:20213. [IV]

    26 Woolf SH, Grol R, Hutchinson A, et al. Potential benefits, limitations andharms of clinical guidelines. BMJ1999;318:52730.

    27 Agency for Health Care Policy and Research. Acute painmanagement, operative or medical procedures and trauma. Clinicalpractice guidelines. Publication no. 92-0032. Rockville, Maryland, USA:Agency for Healthcare Policy and Research Publications, 1992.

    28 Petrie GJ, Barnwell E, Grimshaw J, on behalf of the ScottishIntercollegiate Guidelines Network. Clinical guidelines criteria forappraisal for national use. Edinburgh: Royal College of Physicians,1995.

    29 Vail WJ, Alway AE, England NJ. Spontaneous pneumothorax. Dis Chest1963;38:5125. [III]

    30 Serementis MG. The management of spontaneous pneumothorax. Chest1970;57:658. [III]

    31 Wait MA, Estrera A. Changing clinical spectrum of spontaneouspneumothorax. Am J Surg 1992;164:52831. [III]

    32 Tanaka F, Itoh M, Esaki H, et al. Secondary spontaneous pneumothorax.Ann Thorac Surg 1993;55:3726. [III]

    33 Pavlin DJ, Cheney FW Jr. Unilateral pulmonary edema in rabbits afterre-expansion of collapsed lung. J Appl Physiol1979;46:315. [IIb]

    34 Miller WC, Toon R, Palat H, et al. Experimental pulmonary edemafollowing re-expansion of pneumothorax. Am Rev Respir Dis1973;108:6646. [Ib]

    35 Norris RM, Jones JG, Bishop JM. Respiratory gas exchange in patientswith spontaneous pneumothorax. Thorax1968;23:42733. [IIb]

    36 Light RW, OHara VS, Moritz TE, et al. Intrapleural tetracycline for theprevention of recurrent spontaneous pneumothorax: results of aDepartment of Veterans Affairs Co-operative Study. JAMA1990;264:222430. [Ib]

    37 Schramel FM, Wagenaar M, Sutedja TA, et al. Diagnosis ofpneumothorax not improved by additional roentgen pictures of the thoraxin the expiratory phase. Ned Tijdschr Geneesk1995;139:1313. [IIb]

    38 Schramel FM, Golding RP, Haakman CD, et al. Expiratory chestradiographs do not improve visibility of small apical pneumothoraces byenhanced contrast. Eur Resp J1996;9:4069. [IIb]

    39 Glazer H, Anderson DJ, Wilson BS, et al. Pneumothorax: appearanceson lateral chest radiographs. Radiology1989;173:70711. [III]

    40 Carr JJ, Reed JC, Choplin RH, et al. Plain and computed radiographyfor detecting experimentally induced pneumothorax in cadavers:implications for detection in patients. Radiololgy1992;183:1939. [IIb]

    41 Bourgouin P, Cousineau G, Lemire P, et al. Computed tomography usedto exclude pneumothorax in bullous lung disease. J Can Ass Radiol1985;36:3412. [IV]

    42 Collins CD, Lopez A, Mathie A, et al. Quantification of pneumothoraxsize on chest radiographs using intrapleural distances: regressionanalysis based on volume measurements from helical CT. AJR1995;165:112730. [III]

    Audit points

    Proportion of patients treated by (a) simple observation, (b)aspiration, and (c) chest drains and their appropriateness(relative to the guidelines) and outcome (in terms ofrecurrence rates, complications, and lengths of stay in hos-pital)

    Number of chest drains clamped and the reasons for this. Referral rates to physicians and surgeons and the timing of

    such referrals.

    Use of analgesics and local anaesthetics. Follow up rates

    Future potential areas for research

    Prospective randomised controlled trials comparing: simple observation versus aspiration tube drainage

    for primary pneumothoraces larger than 2 cm on thechest radiograph;

    use of small catheter/Heimlich valve kits versus inter-costal tube drainage following failed aspiration inprimary pneumothoraces;

    small catheter aspiration (CASP) versus conventionalaspiration or tube drainage;

    VATS versus open thoracotomy for the difficult pneu-mothorax. Use of suction with regard to its timing and optimal mode. Comparison of clamping and non-clamping strategies

    after cessation of air leak.

    ii50 Henry, Arnold, Harvey

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    13/14

    43 Engdahl O, Toft T, Boe J. Chest radiograph: a poor method fordetermining the size of a pneumothorax. Chest1993;103:269. [IIb]

    44 Philips GD, Trotman-Dickenson B, Hodson ME, et al. Role of CT in themanagement of pneumothorax in patients with complex cystic lungdisease. Chest1997;112:2758. [IV]

    45 Jordan KG, Kwong JS, Flint J, et al. Surgically treated pneumothorax.Radiologic and pathologic findings. Chest1997;111:2805. [III]

    46 Stradling P, Poole G. Conservative management of spontaneouspneumothorax. Thorax1966;21:1459. [III]

    47 Flint K, Al-Hillawi AH, Johnson NM. Conservative management ofspontaneous pneumothorax. Lancet1984;ii: 6878. [III]

    48 ORourke JP, Yee ES. Civilian spontaneous pneumothorax: treatmentoptions and long term results. Chest1989;96:13026. [III]

    49 Northfield TC. Oxygen therapy for spontaneous pneumothorax. BMJ1971;4:868. [IIa]50 Kirchen LT Jr, Swartzel RL. Spontaneous pneumothorax and its

    treatment. JAMA 1954;155:249. [III]51 Archer GJ, Hamilton AAD, Upadhyag R, et al. Results of simple

    aspiration of pneumothoraces. Br J Dis Chest1985;79:17782. [III]52 Ng AWK, Chan KW, Lee SK. Simple aspiration of pneumothorax.

    Singapore Med J1994;35:502. [IIb]53 Noppen M, Alexander P, Driesen P, et al. Manual aspiration versus

    chest tube drainage in first episodes of primary spontaneouspneumothorax. Am J Respir Crit Care Med 2002;165:12404. [Ib]

    54 Spencer-Jones J. A place for aspiration in the treatment of spontaneouspneumothorax. Thorax1985;40:667. [III]

    55 Andrivert P, Djedaim K, Teboul J-L, et al. Spontaneous pneumothorax:comparison of thoracic drainage vs immediate or delayed needleaspiration. Chest1995;108:33540. [Ib]

    56 Harvey J, Prescott RJ. Simple aspiration versus intercostal tube drainagefor spontaneous pneumothorax in patients with normal lungs. BMJ1994;309:13389. [Ib]

    57 Vallee P, Sullivan M, Richardson H, et al. Sequential treatment of asimple pneumothorax. Ann Emerg Med1988;17:93647. [IIb]

    58 Delius RE, Obeid FN, Horst HM, et al. Catheter aspiration for simplepneumothorax. Arch Surg 1989;124:8336. [IIb]

    59 Laub M, Milman N, Mller D. Role of small calibre chest tube drainagefor iatrogenic pneumothorax. Thorax1990;45:7489. [IIb]

    60 Playfair EE. Case of empyema treated by aspiration and subsequentlyby drainage. BMJ1875;1:4550. [IV]

    61 Graham EA, Bell RD. Open pneumothorax: its relation to the treatmentof empyema. Am J Med Sci1918;156:83943. [IV]

    62 Kenyon JH. Traumatic haemothorax: siphon drainage. Ann Surg1916;64:7289. [IV]

    63 Symbas PN. Chest drainage tubes. Surg Clin North Am 1989;69:416.[IV]

    64 Harriss DR, Graham TR. Management of intercostal drains. Br J HospMed1991;45:3836. [IV]

    65 Baumann MH, Strange C, Heffner JE, et al. Management ofspontaneous pneumothorax. An American College of Chest PhysiciansDelphi Consensus Statement. Chest2001;119:590602.

    66 Seaton D, Yoganathan K, Coady T, et al. Spontaneous pneumothorax:marker gas technique for predicting outcome of manual aspiration. BMJ1991;302:2625. [IIb]

    67 Engdahl O, Boe J, Sandstedt S. Intrapleural bupivocaine for analgesiaduring chest drainage treatment for pneumothorax. A randomised doubleblind trial. Acta Anaesthesiol Scand1993;37:14953. [Ib]

    68 Sherman S, Ravikrishnan KP, Patel A, et al. Optimum anaesthesia withintrapleural lidocaine during chemical pleurodesis with tetracycline.Chest1993;3:5336. [IIb]

    69 Curtin JJ, Goodman LR, Quebbeman EJ, et al. Thoracostomy tubes afteracute chest injury: relationship between location in a pleural fissure andfunction. AJR1994;163:133942. [IIb]

    70 Holden MP, ed. Management of intercostal drainage tubes. In: Practiceof cardiothoracic surgery. Bristol: John Wright, 1982: 3.

    71 Daly RC, Mucha P, Pairolero PC, et al. The risk of percutaneous chesttube thoracostomy for blunt thoracic trauma. Ann Emerg Med1985;14:86570. [IV]

    72 Iberti TJ, Stern PM. Chest tube thoracostomy. Crit Care Clin1992;14:87995. [IV]

    73 Miller KS, Sahn FA. Chest tubes: indications, technique, managementand complications. Chest1987;91:25864. [Review]

    74 Chan L, Reilly KM, Henderson C, et al. Complication rates of tubethoracostomy. Am J Emerg Med1997;15:36870. [III]

    75 Baldt MM, Bankier AA, Germann PS, et al. Complications afteremergency tube thoracostomy: assessment with CT. Radiology1995;195:53943. [III]

    76 Brunner RG, Vinsant GO, Alexander RH, et al. The role of antibiotictherapy in the prevention of empyema in patients with an isolated chestinjury: a prospective study. J Trauma 1990;30:114853. [Ib]

    77 Nichols RI, Smith JW, Muzik AC, et al. Preventative antibiotic usage intraumatic injuries requiring chest tube thoracostomy. Chest1994;106:14938. [Ib]

    78 Maunder RJ, Pierson DJ, Hudson LD. Subcutaneous and mediastinalemphysema. Pathophysiology, diagnosis and management. Arch InternMed1984;144:144753. [Review]

    79 Conetta R, Barman AA, Lakovou C, et al. Acute ventilatory failure frommassive subcutaneous emphysema. Chest1993;104:97880. [IV]

    80 So SY, Yu DY. Catheter drainage of spontaneous pneumothorax: suctionor no suction, early or late removal ? Thorax1982;37:468. [IIb]

    81 Bevelaqua FA, Aranda C. Management of spontaneous pneumothoraxwith small lumen catheter manual aspiration. Chest1982;81:6935. [III]

    82 Conces Jr DJ, Tarrer RD, Cory Gray W, et al. Treatment ofpneumothoraces utilising small calibre chest tubes. Chest1988;94:557.[III]

    83 Minami H, Saka H, Senda K, et al. Small calibre catheter drainage forspontaneous pneumothorax. Am J Med Sci1992;304:3457. [IIb]

    84 Tattersall DJ, Traill ZC, Gleeson FV. Chest drains: Does Size Matter?Clin Radiol2000;55:41521. [IV]

    85 Sharma TN, Agrihotri SP, Jain NK, et al. Intercostal tube thoracostomyin pneumothorax: factors influencing re-expansion of lung. Ind J Chest DisAllied Sci1988;30:325. [III]

    86 Mathur R, Cullen J, Kinnear WJM, et al. Time course of resolution ofpersistent air leak in spontaneous pneumothorax. Respir Med1995;89:12932. [IIb]

    87 Enerson DM, McIntyre RN. A comparative study of the physiology andphysics of pleural drainage systems. J Thorac Cardiovasc Surg1966;52:404. [IIb]

    88 Munnell E. Thoracic drainage. Ann Thorac Surg 1997;63:1497502.[IV]

    89 Roe BB. Physiologic principles of drainage of the pleural space. Am JSurg 1958;96:2469. [Review]

    90 Pierson DJ. Persistent bronchopleural air-leak during mechanicalventilation: a review. Respir Care1982;27:40815. [Review]

    91 Granke K, Fischer CR, Gago O, et al. The efficacy and timing ofoperative intervention for spontaneous pneumothorax. Ann Thorac Surg1986;42:5402. [IIa]

    92 Schonenberger RA, Haefeli HA, Weiss P, et al. Timing of invasiveprocedures for primary and secondary spontaneous pneumothorax. ArchSurg 1991;126:76466. [III]

    93 Shah SS, Cohen AS, Magee PG, et al. Surgery remains a late andunder-utilised option in the management of spontaneous pneumothorax:should the British Thoracic Society guidelines be revisited ? Thorax1998;53(Suppl 4):A52. [III]

    94 Pavlin DJ, Nessly MC, Cheney FW. Increased pulmonary vascularpermeability as a cause of re-expansion pulmonary edema in rabbits. Am

    Rev Respir Dis 1981;124:4227. [IIa]95 Mafhood S, Hix WR, Aaron BI, et al. Re-expansion pulmonary edema.

    Ann Thorac Surg 1988;45:3405. [IV]96 Matsuura Y, Nomimura T, Nurikami H, et al. Clinical evidence of

    re-expansion pulmonary edema. Chest1991;100:15626. [III]97 Almind M, Lange P, Viskum K. Spontaneous pneumothorax: comparison

    of simple drainage, talc pleurodesis and tetracycline pleurodesis. Thorax1989;44:62730. [Ib]

    98 Olsen PS, Anderson HO. Long term results after tetracycline pleurodesisin spontaneous pneumothorax. Ann Thorac Surg 1992;53:10157. [IIb]

    99 Massard G, Thomas P, Wihlm J-M. Minimally invasive management forfirst and recurrent pneumothorax. Ann Thorac Surg 1998;66:5929.[Review]

    100 Torre M, Grassi M, Nerli FP, et al. Nd-Yag lasar pleurodesis viathoracoscopy. Chest1994;106:33841. [IIb]

    101 Vargas FS, Wang N-S, Lee HM, et al. Effectiveness of bleomycin incomparison to tetracycline as pleural sclerosing agents in rabbits. Chest1993;104:15824. [IIb]

    102 Van den Brande P, Staelans I. Chemical pleurodesis in primaryspontaneous pneumothorax. J Thorac Cardiovasc Surg 1989;37:1802.[Ib]

    103 Alfageme I, Moreno L, Heurtas C, et al. Spontaneous pneumothorax:long term results with tetracycline pleurodesis. Chest; 1994:106:34750. [IIa]

    104 Light RW, Wang N-S, Sassoon CS, et al. Comparison of theeffectiveness of tetracycline and minocycline as pleural sclerosing agentsin rabbits. Chest1994;106:57782. [IIb]

    105 Hurewitz AN, Lidonicci K, Wu CL, et al. Histologic changes ofdoxycycline pleurodesis in rabbits. Chest1994;106:12415. [IIb]

    106 Wang YT, Ng KY, Poh SC. Intrapleural tetracycline for spontaneouspneumothorax with persistent air leak. Singapore Med J1988;29:723.[IV]

    107 Macoviak JA, Stephenson LW, Ochs R, et al. Tetracycline pleurodesisduring active pulmonary-pleural air leak for prevention of recurrentpneumothorax. Chest1982;81:7881. [Ib]

    108 Chee CB, Abishaganaden J, Yeo JK, et al. Persistent air-leak inspontaneous pneumothorax - clinical course and outcome. Respir Med1998;92:75761. [III]

    109 Thvenet F, Gamonds JP, Bodzongo D, et al. Spontaneous andrecurrent pneumothorax. Surgical review of 278 cases. Ann Chir1992;46:1659. [III]

    110 Weedon D, Smith GH. Surgical experience in the management ofspontaneous pneumothorax, 19721982. Thorax1983;38:73743.[IV]

    111 Krner H, Anderson KS, Strangeland L, et al. Surgical treatment ofspontaneous pneumothorax by wedge resection without pleurodesis orpleurectomy. Eur J Cardiothorac Surg 1996;10:6569. [III]

    112 Thomas P, Le Mee F, Le Hors H, et al. Results of surgical treatment ofpersistent or recurrent pneumothorax. Ann Chir1993;47:13640. [III]

    113 Waller DA, McConnell SA, Rajesh PB. Delayed referral reduces thesuccess of video-assisted thoracoscopic surgery for spontaneouspneumothorax. Respir Med1998;92:2469. [III]

    114 Inderbitzi RG, Leiser A, Furrer M, et al. Three years experience invideo-assisted thoracic surgery (VATS) for spontaneous pneumothorax. JThorac Cardiovasc Surg 1994;107:14105. [III]

    115 Cran IR, Rumball CA. Survey of spontaneous pneumothorax in the RoyalAir Force. Thorax1967;22:4625. [IV]

    116 Parry GN, Juniper ME, Dussek JE. Surgical intervention in spontaneouspneumothorax. Respir Med1992;86:12. [Review]

    BTS guidelines for the management of spontaneous pneumothorax ii51

    www.thoraxjnl.com

  • 7/27/2019 Pleural Disease Spontaneous

    14/14

    117 Gaensler EA. Parietal pleurectomy for recurrent spontaneouspneumothorax. Surg Gynecol Obstet1956;102:293308. [IV]

    118 Claggett OT. The management of spontaneous pneumothorax. J ThoracCardiovasc Surg 1968;55:7612. [IV]

    119 Tyson MD, Crandall WB. The surgical treatment of recurrent idiopathicspontaneous pneumothorax. J Thorac Surg 1941;10:56670. [III]

    120 Waller DA, Forty J, Morritt GN. Video-assisted thoracoscopic surgeryversus thoracotomy for spontaneous pneumothorax. Ann Thorac Surg1994;58:3737. [IIb]

    121 Waller DA. Video-assisted thoracoscopic surgery (VATS) in themanagement of spontaneous pneumothorax. Thorax1997;52:3078.[Review]

    122 Naunheim KS, Mack MJ, Hazelrigg SR, et al. Safety and efficacy of

    video-assisted thoracic surgical techniques for the treatment ofspontaneous pneumothorax. J Thorac Cardiovasc Surg1995;109:1198204. [III]

    123 Horio H, Nomori H, Fuyuno G, et al. Limited axillary thoracotomy vsvideo-assisted thoracoscopic surgery for spontaneous pneumothorax.Surg Endosc1998;12:11558. [III]

    124 Simansky DA, Yellin A. Pleural abrasion via axillary thoracotomy in theera of video assisted thoracic surgery. Thorax1994;49:9223. [III]

    125 Deslauriers J, Beaulieu M, Desprs JP, et al. Transaxillary pleurectomyfor treatment of spontaneous pneumothorax. Ann Thorac Surg1980;30:56774. [III]

    126 Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothoraxand pleural effusion. Chest1994;106:121522. [Ia]

    127 Dumont P, Diemont F, Massard G, et al. Does a thorascopic approachfor surgical treatment of spontaneous pneumothorax represent progress ?Eur J Cardiothorac Surg 1997;11:2231. [III]

    128 Tschopp JM, Brutsche M, Frey JG. Treatment of complicatedpneumothorax by simple talc pleurodesis under thoracoscopy and localanaesthesia. Thorax1997;52:32932. [III]

    129 Liu H-P, Lin PJ, Hsieh M-J, et al. Thoracoscopic surgery as a routine

    procedure for spontaneous pneumothorax. Chest1995;107:55962.[IV]130 Verschoof AC, TenVelde GP, Greve LH, et al. Thorascopic pleurodesis

    in the management of spontaneous pneumothorax. Respiration1988;53:197200. [IIb]

    131 Hansen AK, Nielsen PH, Mller NG, et al. Operative pleurodesis inspontaneous pneumothorax. Scand J Thorac Cardiovasc Surg1989;23:27981. [IV]

    132 Webb WR, Ozman V, Moulder PV, et al. Iodized talc pleurodesis for thetreatment of pleural effusions. J Thorac Cardiovasc Surg1992;103:8816. [IV]

    133 Rinaldo JE, Owens GR, Roger RM. Adult respiratory distress syndromefollowing intrapleural instillation of talc. J Thorac Cardiovasc Surg1983;85:5236. [IV]

    134 Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry.Chest1994;106:3426. [IV]

    135 Hamed H, Fentiman IS, Chaudary MA, et al. Comparison of bleomycinand talc for the control of pleural effusions secondary to carcinoma of thebreast. Br J Surg 1989;76:12667. [IIb]

    136 Becker RM, Munro DD. Transaxillary minithoracotomy: the optimalapproach for certain pulmonary and mediastinal lesions. Ann Thorac

    Surg 1976;22:2549. [IV]137 Kim KH, Kim HK, Han JY, et al. Transaxillary minithoracotomy versus

    video-assisted thoracic surgery for spontaneous pneumothorax. AnnThorac Surg 1996;61:15102. [Ib]

    138 Mouroux J, Elkam D, Padavoni B, et al. Video-assisted thoracoscopictreatment of spontaneous pneumothorax: technique and results of onehundred cases. J Thorac Cardiovasc Surg 1996;112:38591. [IV]

    139 Rm OJ, Salo JA, Mattila SP. Video-assisted thoracoscopic pleurectomyin the treatment of recurrent spontaneous pneumothorax. Ann ChirGynaecol1995;84:2725. [IIb]

    140 Nathanson LK, Shimi SM, Wood RA, et al. Videothorascopic ligation ofbullae and pleurectomy for spontaneous pneumothorax. Ann Thorac Surg1991;52:3169. [IV]

    141 Fosse E, Fjeld NB, Brockmeier V, et al. Thoracoscopic pleurodesis.Scand J Thor Cardiovasc Surg 1993;27:1179. [IV]

    142 Bertrand PC, Regnard JP, Spaggiari L, et al. Immediate and long termresults after surgical treatment of primary spontaneous pneumothorax byVATS. Ann Thorac Surg 1996;61:16415. [III]

    143 Gebhard FT, Becker HP, Gerngross H, et al. Reduced inflammatoryresponse in minimally invasive surgery of pneumothorax. Arch Surg

    1996;131:107982. [IIb]144 Cole Jr FH, Cole FH, Khandekar A, et al. Video-assisted thoracicsurgery: primary therapy for spontaneous pneumothorax? Ann ThoracSurg 1995;60:9315. [IIb]

    145 Sekine Y, Miyata Y, Yamada H, et al. Video-assisted thoracoscopicsurgery does not deteriorate postoperative pulmonary gas exchange inspontaneous pneumothorax patients. Eur J Cardiothorac Surg1999;16:4853. [Ib]

    146 Waller DA, Forty J, Soni AK, et al. Videothoracoscopic operation forsecondary spontaneous pneumothorax. Ann Thorac Surg1994;57:16125. [IV]

    147 British Thoracic Society Standards of Care Committee. Managingpassengers with respiratory disease planning air travel: British ThoracicSociety recommendations. Thorax2002;57:289304.

    148 Ziser A, Vaananen A, Melamed Y. Diving and chronic spontaneouspneumothorax. Chest1985;87:2645. [IV]

    149 British Thoracic Society Fitness to Dive Group. BTS guidelines onrespiratory aspects of fitness for diving. Thorax2003;58:311.

    150 Light RW, Hamm H. Pleural disease and acquired immune deficiencysyndrome. Eur Respir J1997;10:263843. [IV]

    151 Sepkowitz KA, Telzac EE, Gold JW, et al. Pneumothorax in AIDS. AnnIntern Med1991;114:4559. [III]

    152 Gerein AN, Brumwell ML, Lawson LM, et al. Surgical management ofpneumothorax in patients with acquired immune deficiency syndrome.Arch Surg 1991;126:12727. [IV]

    153 Delorenzo LT, Huang CT, Maguire GP, et al. Roentgenographic patternsof Pneumocystis carinii in 104 patients with AIDS. Chest1987;91:3237. [IV]

    154 Suster B, Akerman M, Grenstein M, et al. Pulmonary manifestations ofAIDS: review of 106 episodes. Radiology1986;161:8793. [IV]

    155 Eng RH, Bishburg E, Smith SM. Evidence for destruction of lung tissueduring Pneumocystis carinii infection. Arch Intern Med1987;147:7469.[IV]

    156 Fenerstein IM, Archer A, Pluda JM. Thin walled cavities, cysts andpneumothorax in Pneumocystis carinii pneumonia; further observationand histopathological correlation. Radiology1990;174:197202. [IIb]

    157 Wait MA, Dal Nogare AR. Treatment of AIDS-related spontaneouspneumothorax: a decade of experience. Chest1994;106:6936. [IV]

    158 Metersky ML, Colt HG, Olson LK, et al. AIDS-related spontaneouspneumothorax. Risk factors and treatment. Chest1995;108:94651.[IIb]

    159 Joe L, Gordin F, Parker RH. Spontaneous pneumothorax withPneumocystis carinii infection. Arch Intern Med1986;146:18167. [IV]

    160 Beers MF, Sohn M, Swartz M. Recurrent pneumothorax in AIDS patientswith pneumocystis pneumonia. Chest1990;98:26670. [IV]161 Coker RJ, Peters MB, McCarthy M, et al. Pneumothorax in patients with

    AIDS. Respir Med1993;87:437. [IV]162 Asboe D, Fisher M, Nelson MR et al. Pneumothorax in AIDS: case

    reviews and proposed clinical management. Genitourinary Med1996;72:25860. [III]

    163 Spector ML, Stern SC. Pneumothorax in cystic fibrosis. Ann Thorac Surg1989;47:2047. [IV]

    164 Tribble G, Selden R, Rodgers B. Talc poudrage in the treatment ofspontaneous pneumothoraces in patients with cystic fibrosis. Ann Surg1986;204:67780. [III]

    165 Davis P, di SantiAgnese PA. Diagnosis and treatment of cystic fibrosis:an update. Chest1984;85:8029. [Review]

    166 Schuster SR, McLaughlin J, Matthews WJ, et al. Management ofpneumothorax in adults with cystic fibrosis. J Pediatr Surg1983;18:4927. [IV]

    167 Penketh A, Knight RK, Hodson ME, et al. Management of pneumothoraxin cystic fibrosis. Thorax1982;37:8503. [IV]

    168 Noyes BE, Orenstein DM. Treatment of pneumothorax in cystic fibrosis in

    the era of lung transplantation. Chest1992;101:11878. [III]169 Light RW. Tension pneumothorax. Intensive Care Med1994;20:4689.

    [IV]170 Baumann MH, Sahn SA. Tension pneumothorax: diagnostic and

    therapeutic pitfalls. Crit Care Med1994;22:896. [IV]171 Tocino IM, Miller MH, Fairfax WR. Distribution of pneumothorax in the

    supine and semi-recumbent critically ill adult. AJR1985;144:9014. [III]172 American College of Surgeons Committee On Trauma. Thoracic

    trauma. In: Advanced Trauma Life Support programme for physicians:instructor manual. Chicago: American College of Surgeons, 1993.

    173 Britten S, Palmer SH, Snow TM. Needle thoracocentesis in tensionpneumothorax: insufficient cannula length and potential failure. Injury1996;27:3212. [III]

    174 Bristol JB. Harvey JE. Safer insertion of pleural drains. BMJ1983;286:3489. [IV]

    175 Sassoon CS, Light RW, OHara VS, et al. Iatrogenic pneumothorax:aetiology and morbidity. Respiration 1992;59:21520. [IV]

    176 Despars JA, Sassoon CS, Light RW. Significance of iatrogenicpneumothoraces. Chest1994;105:114750. [IV]

    177Poe RH

    , Kullay MC, Wicks CM, et al. Predicting risk of pneumothorax inneedle biopsy of the lung. Chest1984;85:2325. [III]178 Berger R, Smith D. Efficacy of the lateral decubitus position in preventing

    pneumothorax after needle biopsy of the lung. South Med J1988;81:11403. [IIa]

    179 Anderson CL, Crespo JC, Lie TH. Risk of pneumothorax not increased byobstructive lung disease in percutaneous needle biopsy. Chest1994;105:17058. [IV]

    180 Pollack MM, Fields AI, Holbrook PR. Pneumothorax andpneumomediastinum during pediatric mechanical ventilation. Crit CareMed1979;7:5369. [IV]

    ii52 Henry, Arnold, Harvey